The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Lancaster James C Jr since year 2005.
The trader's CIK number is 1396927.
At the time of this reporting, Lancaster James C Jr is the VP of Commercial Ope of Orexigen Therapeutics, Inc. .
(stock ticker symbol OREX).
See this page for all insider trading activities at Orexigen Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2007-12-26||OREX||Orexigen Therapeutics, Inc.||Sale||3,000||15.02||45,072|
|2007-12-26||OREX||Orexigen Therapeutics, Inc.||Option Ex||3,000||2.00||6,000|
|2007-11-26||OREX||Orexigen Therapeutics, Inc.||Sale||3,000||14.41||43,239|
|2007-11-26||OREX||Orexigen Therapeutics, Inc.||Option Ex||3,000||2.00||6,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lancaster James C Jr (VP of Commercial Ope of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.